search
Back to results

Opioid Free VS Opioid Anesthesia for Craniotomies

Primary Purpose

Supratentorial Neoplasms

Status
Completed
Phase
Phase 1
Locations
Egypt
Study Type
Interventional
Intervention
Opioid free anesthetics
Opioid Anesthetics
Sponsored by
Kasr El Aini Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Supratentorial Neoplasms focused on measuring Opioid free Anesthesia, Craniotomies, Dexmedetomidine, Ketamine, Fentanyl, Lidocaine, Magnesium sulphate, supratentorial tumors

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • ASA Ι and II.
  • Patients undergoing surgeries for removal of supratentorial tumors.
  • Age (18-60) years.
  • Both sexes.

Exclusion Criteria:

  • Impaired renal functions.
  • Systemic hypertension.
  • Dysrhythmia.
  • Heart failure.
  • Glasgow coma scale less than 12.
  • The need for postoperative ventilation.
  • History of allergy to the study drugs.
  • Surgeries lasting more than 6 hours.
  • Pregnancy.
  • Bronchial asthma

Sites / Locations

  • Kasr El Aini Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Opioid free anesthesia

Opioid anesthesia

Arm Description

patients are going to receive intraoperative analgesics other than opioids

patients are going to receive intraoperative opioid analgesics

Outcomes

Primary Outcome Measures

Percentage of patients experiencing a change in mean arterial pressure at time of Burr Hole
Defined as recording an increase or decrease of the mean arterial blood pressure by more than 25 % from baseline readings at the time of burr hole

Secondary Outcome Measures

HR (heart rate) in beats/min
Hemodynamic parameter recorded during the study
Brain relaxation score
Defined as 1= excellently relaxed, 2= satisfactory relaxed, 3= leveled, 4=bulging
Number of patients requiring antihypertensive medication
Number of patients needing nitroglycerine infusion in each group was recorded together with total amount infused
Number of patients requiring medication to increase blood pressure
Number of patients needing ephedrine in each group was recorded together with total amount infused.
Time to extubation
Defined as the time between the discontinuation of inhalation agents and extubation
Ramsay Sedation Scale (RSS)
to assess the postoperative sedation, it is a scale from 1 to 6. It provides three levels of 'awake' states (score 1-3) and three levels of 'asleep' states (score 4-6). A score of 2 (patient is cooperative, orientated and tranquil)
Systolic blood pressure (SBP) in mmhg
Hemodynamic parameter recorded during the study
Mean arterial blood pressure (MAP) in mmhg
Hemodynamic parameter recorded during the study

Full Information

First Posted
June 12, 2021
Last Updated
October 17, 2021
Sponsor
Kasr El Aini Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04941040
Brief Title
Opioid Free VS Opioid Anesthesia for Craniotomies
Official Title
Hemodynamic Effects of Opioid Free Anesthesia Versus Opioid Anesthesia on Adult Patients Undergoing Craniotomies for Supratentorial Tumors. Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2021
Overall Recruitment Status
Completed
Study Start Date
July 5, 2021 (Actual)
Primary Completion Date
October 3, 2021 (Actual)
Study Completion Date
October 3, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Kasr El Aini Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Hemodynamic control during craniotomies can be a bit hectic specially during periods of intense noxious stimulation. For long anesthesiologists used high doses of opioids such as fentanyl and remifentanyl to provide analgesia with a good hemodynamic control during intraoperative period in patients undergoing craniotomies. However, the use of opioids was not devoid of side effects. Exploring other anesthetic plans using multiple opioid free anesthetic adjuvants that have analgesic effects given together in small doses appear to be appealing plan. This idea is the basis of our proposed study in which we compare the hemodynamic effects of using opioid free anesthesia versus opioid anesthesia in cranial surgeries.
Detailed Description
Anesthesia for craniotomies can be very challenging because of the presence of periods of noxious stimuli that interposes with periods of little stimulation which makes hemodynamic control a little bit more complicated. Intraoperative episodes of hypertension during periods of intense stimulations and early postoperative hypertension may lead to serious complications as post craniotomy intracranial hemorrhage and vasogenic brain edema. Anesthetic techniques based on usage of high doses of potent opioid analgesics such as fentanyl and remifentanil have been widely popular among anesthesiologists. However, the intra operative use of large bolus doses or continuous infusions of potent opioids may be associated with postoperative hyperalgesia and increased analgesic consumption. More recently, concerns have arisen about impaired healing,immunosuppression,and worsening of oncologic outcomes with systemic opioids. Another technique that started gaining its popularity is opioid free anesthesia (OFA) technique whose corner stone is depending on multiple anesthetic adjuvants that have analgesic effects, , therefore when given together in small doses they result in good anesthesia with less side effects and faster recovery compared with opioids. This technique has been successfully used in anesthesia for bariatric surgeries combining multiple drugs as dexmedetomidine, lidocaine, ketamine, ketorolac and magnesium. Dexmedetomidine is a highly selective α2-adrenoceptor agonist with sedative, anxiolytic and analgesic properties that has minimal effects on respiratory drive. Although preoperative intravenous dexmedetomidine administration is associated with a reduction in postoperative pain intensity, analgesic consumption and nausea, the analgesic property of dexmedetomidine is less effective compared with opioids. Intravenous lidocaine has been described as having analgesic, anti-hyperalgesic, and anti-inflammatory properties. Intravenous lidocaine infusion in the perioperative period is safe and has clear advantages, such as decreased intra operative anesthetic requirements, lower pain scores, reduced postoperative analgesic requirements, as well as faster recovery. In addition to ketamine magnesium is also reported to enhance analgesia by blocking NMDA receptor, also magnesium has the properties of a sympatholytic and has been introduced as a safe component of balanced anesthesia. This comparative study between Opioid free anesthesia (OFA) and Opioid anesthesia (OA) aims to compare the effect of both techniques on intra operative hemodynamics, intracranial tension and recovery in cranial surgeries for supratentorial tumors. After obtaining an informed written consent from the patients or their responsible relative, patients will be divided into 2 groups randomly using computer software (research randomizer.org); Opioid free Anesthesia group (OFA) and Opioid Anesthesia group (OA). To assure blindness, numbers will be concealed by closed envelope, analgesic infusions will prepared by a clinical pharmacist not included in data collection and the attending anesthetist will be blinded to the type of analgesic solution injected. Over 10 minutes prior to induction of analgesia patients in the OFA group will receive small doses of demedetomidine, ketamine, lidocaine and magnesium along with ketorlac and acetaminophen. an infusion afterwards will be administered through the operation containing dexmedetomidine, ketamine and lidocaine. In the OA group, over 10 minutes, patients will receive a loading dose of fentanyl followed by fentanyl infusion through the operation. General anesthesia will be induced using the same drugs and the same parameters in both groups after the completion of the initial analgesic infusions The primary outcome parameter will be the percentage of patients experiencing hemodynamic instability at Burr Hole (defined as recording an increase or decrease of the mean arterial blood pressure by 25 % of the baseline reading) Assuming the rate of hemodynamic instability (defined as increase or decrease of the mean blood pressure by 25 % of the baseline reading) would be 40 % in the control arm, a clinically meaningful reduction of the rate of hemodynamic instability to 10 % in the investigational arm with a statistical power of 80 % and an alpha error of less than 0.05 would require recruiting 29 patients in each group (a total of 58 patients). Continuous data will be presented as mean + (SD). Categorical variables will be represented as frequencies and percentages. According to the type of data Comparison between the two groups will be performed using either Chi square test or Fisher's exact test. Hemodynamic variables will be compared to baseline using repeated measures analysis of variance (ANOVA) with post hoc scheffe's test for positive data. P values less than 0.05 will be considered statistically significant.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Supratentorial Neoplasms
Keywords
Opioid free Anesthesia, Craniotomies, Dexmedetomidine, Ketamine, Fentanyl, Lidocaine, Magnesium sulphate, supratentorial tumors

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 1
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Opioid free anesthesia
Arm Type
Experimental
Arm Description
patients are going to receive intraoperative analgesics other than opioids
Arm Title
Opioid anesthesia
Arm Type
Active Comparator
Arm Description
patients are going to receive intraoperative opioid analgesics
Intervention Type
Drug
Intervention Name(s)
Opioid free anesthetics
Other Intervention Name(s)
OFA
Intervention Description
Patients will receive over the 10 minutes prior to induction: Acetaminophen 1 gm i.v. infusion in 100ml over 10 minutes. Ketorolac 30 mg i.v. infusion in100 ml over 10 minutes. Mg SO4 loading dose 30 mg/kg i.v. infusion in 100 ml over 10 minutes. Dexmedetomidine loading dose 1 μg/kg i.v. infusion. Lidocaine loading dose 1.5 mg/kg i.v. infusion. Ketamine loading dose 0.25 mg/kg i.v. infusion. The weight based doses of dexmedetomidine, lidocaine, ketamine will be prepared on 20 ml syringe and infused over 10 minutes prior to induction. In a dose of 0.1 ml/kg Then after induction maintenance analgesic infusion will start in a rate that ranges from 0.025 to 0.05 ml/kg/h which is equivalent to: Dexmedetomidine 0.25-0.5 μg/kg/h Lidocaine 0.375-0.75 mg/kg/h Ketamine 0.0625- 0.125 mg/kg/h
Intervention Type
Drug
Intervention Name(s)
Opioid Anesthetics
Other Intervention Name(s)
OA
Intervention Description
Placebo equivalent to acetaminophen, ketorolac, magnesium sulphate will be infused as 100 ml normal saline each over 10 minutes ,patients will receive fentanyl 2 μg/kg loading dose which will be prepared over 20 ml syringe and infused over 10 minutes prior to induction, Then after induction maintenance of analgesic infusion by fentanyl 0.5-1 μg/kg/h.
Primary Outcome Measure Information:
Title
Percentage of patients experiencing a change in mean arterial pressure at time of Burr Hole
Description
Defined as recording an increase or decrease of the mean arterial blood pressure by more than 25 % from baseline readings at the time of burr hole
Time Frame
During Burr hole surgery
Secondary Outcome Measure Information:
Title
HR (heart rate) in beats/min
Description
Hemodynamic parameter recorded during the study
Time Frame
Baseline, pre-induction, pre-intubation, after intubation, skin incision, burr hole, dural incision, dural closure, skin closure, every 30 minutes intraoperative till extubation, time of extubation, every 15 minutes for 2 hours in PACU.
Title
Brain relaxation score
Description
Defined as 1= excellently relaxed, 2= satisfactory relaxed, 3= leveled, 4=bulging
Time Frame
At the time of dural incision
Title
Number of patients requiring antihypertensive medication
Description
Number of patients needing nitroglycerine infusion in each group was recorded together with total amount infused
Time Frame
Throughout the operation
Title
Number of patients requiring medication to increase blood pressure
Description
Number of patients needing ephedrine in each group was recorded together with total amount infused.
Time Frame
Throughout the operation
Title
Time to extubation
Description
Defined as the time between the discontinuation of inhalation agents and extubation
Time Frame
At the end of the operation, the time from the discontinuation of inhalation agents till extubation
Title
Ramsay Sedation Scale (RSS)
Description
to assess the postoperative sedation, it is a scale from 1 to 6. It provides three levels of 'awake' states (score 1-3) and three levels of 'asleep' states (score 4-6). A score of 2 (patient is cooperative, orientated and tranquil)
Time Frame
every 30 minutes for 2 hours postoperative
Title
Systolic blood pressure (SBP) in mmhg
Description
Hemodynamic parameter recorded during the study
Time Frame
Baseline, pre-induction, pre-intubation, after intubation, skin incision, burr hole, dural incision, dural closure, skin closure, every 30 minutes intraoperative till extubation, time of extubation, every 15 minutes for 2 hours in PACU.
Title
Mean arterial blood pressure (MAP) in mmhg
Description
Hemodynamic parameter recorded during the study
Time Frame
Baseline, pre-induction, pre-intubation, after intubation, skin incision, burr hole, dural incision, dural closure, skin closure, every 30 minutes intraoperative till extubation, time of extubation, every 15 minutes for 2 hours in PACU.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ASA Ι and II. Patients undergoing surgeries for removal of supratentorial tumors. Age (18-60) years. Both sexes. Exclusion Criteria: Impaired renal functions. Systemic hypertension. Dysrhythmia. Heart failure. Glasgow coma scale less than 12. The need for postoperative ventilation. History of allergy to the study drugs. Surgeries lasting more than 6 hours. Pregnancy. Bronchial asthma
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rania S Fahmy
Organizational Affiliation
Kasr Al Ainy, Faculty of medicine, Cairo university
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kasr El Aini Hospital
City
Cairo
ZIP/Postal Code
11687
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
18580347
Citation
Uyar AS, Yagmurdur H, Fidan Y, Topkaya C, Basar H. Dexmedetomidine attenuates the hemodynamic and neuroendocrinal responses to skull-pin head-holder application during craniotomy. J Neurosurg Anesthesiol. 2008 Jul;20(3):174-9. doi: 10.1097/ANA.0b013e318177e5eb.
Results Reference
background
PubMed Identifier
10861145
Citation
Basali A, Mascha EJ, Kalfas I, Schubert A. Relation between perioperative hypertension and intracranial hemorrhage after craniotomy. Anesthesiology. 2000 Jul;93(1):48-54. doi: 10.1097/00000542-200007000-00012.
Results Reference
background
PubMed Identifier
16508405
Citation
Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology. 2006 Mar;104(3):570-87. doi: 10.1097/00000542-200603000-00025.
Results Reference
background
PubMed Identifier
26595546
Citation
Mulier JP. Perioperative opioids aggravate obstructive breathing in sleep apnea syndrome: mechanisms and alternative anesthesia strategies. Curr Opin Anaesthesiol. 2016 Feb;29(1):129-33. doi: 10.1097/ACO.0000000000000281.
Results Reference
background
PubMed Identifier
15505442
Citation
Cortinez LI, Hsu YW, Sum-Ping ST, Young C, Keifer JC, Macleod D, Robertson KM, Wright DR, Moretti EW, Somma J. Dexmedetomidine pharmacodynamics: Part II: Crossover comparison of the analgesic effect of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology. 2004 Nov;101(5):1077-83. doi: 10.1097/00000542-200411000-00006.
Results Reference
background
PubMed Identifier
19138915
Citation
Lauwick S, Kim DJ, Michelagnoli G, Mistraletti G, Feldman L, Fried G, Carli F. Intraoperative infusion of lidocaine reduces postoperative fentanyl requirements in patients undergoing laparoscopic cholecystectomy. Can J Anaesth. 2008 Nov;55(11):754-60. doi: 10.1007/BF03016348.
Results Reference
background
PubMed Identifier
33171574
Citation
Syeda S, Palaniswamy SR, Sriganesh K. Opioid Free Analgesia With Dexmedetomidine for Craniotomy in an Obese Patient With Obstructive Sleep Apnea and Difficult Airway. Asian J Anesthesiol. 2020 Jun 1;58(2):76-77. doi: 10.6859/aja.202006_58(2).0007. Epub 2020 Jul 24. No abstract available.
Results Reference
background

Learn more about this trial

Opioid Free VS Opioid Anesthesia for Craniotomies

We'll reach out to this number within 24 hrs